China Next-Gen Commerce and Supply Chain Limited (HKG:3928)

CTI BioPharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	1,800	1,872	576	394	461	278
Market Cap Growth	83.45%	225.00%	46.34%	-14.58%	65.52%	-43.69%
Enterprise Value	1,845	1,926	633	492	528	346
Last Close Price	3.75	3.90	1.20	0.82	0.96	0.58
PS Ratio	4.83	5.52	1.79	1.07	1.69	1.18
PB Ratio	11.27	11.37	3.59	2.48	2.63	1.18
P/TBV Ratio	11.27	11.37	3.59	2.48	2.63	1.18
P/FCF Ratio	146.91	252.85	71.37	51.87	55.15	-
P/OCF Ratio	90.43	98.29	34.20	51.68	45.32	-
EV/Sales Ratio	4.96	5.68	1.97	1.34	1.94	1.47
EV/EBITDA Ratio	252.24	405.40	-	-	-	-
EV/FCF Ratio	150.61	260.21	78.50	64.78	63.21	-
Debt / Equity Ratio	0.52	0.68	0.70	0.88	0.95	0.69
Debt / EBITDA Ratio	11.41	11.98	-	-	-	-
Debt / FCF Ratio	6.83	15.19	13.85	18.32	19.85	-
Asset Turnover	1.02	0.84	0.82	0.90	0.60	0.47
Quick Ratio	1.19	1.13	1.30	1.36	1.37	1.62
Current Ratio	1.21	1.15	1.31	1.37	1.39	1.84
Return on Equity (ROE)	-2.23%	-2.84%	-3.64%	-5.02%	-31.02%	-15.67%
Return on Assets (ROA)	-1.23%	-0.97%	-2.93%	-3.96%	-10.83%	-6.22%
Return on Capital (ROIC)	-1.73%	-1.39%	-3.94%	-5.19%	-13.10%	-7.51%
Earnings Yield	-0.20%	-0.25%	-1.03%	-2.08%	-13.94%	-14.46%
FCF Yield	0.68%	0.40%	1.40%	1.93%	1.81%	-13.05%
Buyback Yield / Dilution	-	-	-	-	-	-31.89%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.